Health and Healthcare
Biotechs and Related Hitting 52-Week Lows Too (BBH, AMGN, AMLN, ARNA, GERN, INGN, PGNX, SUPG)
Published:
Last Updated:
Today has been a rough day with more 52-week lows than we can recall in quite some time. The biotechs haven’t been immune. You can even see that the Biotech HOLDRs (BBH) at $160+ are only about 2% above the 52-week lows of $157.95, while the iShares Nasdaq Biotechnology (IBB) ETF at $80.29 is only about half-way in its 52-week trading range of $72.37 to $89.00. The difference is because of the composition.
Here are BIOTECH STOCKS hitting 52-week lows today:
- Amgen (AMGN)
- Amylin Pharma (AMLN)
- Arena Pharma (ARNA)
- Cleveland Biolabs (CBLI)
- Geron (GERN)
- Introgen (INGN)
- Progenics Pharma (PGNX)
- Somaxon Pharma (SOMX)
- Spectrum Pharma (SPPI)
- Supergen (SUPG)
If you wantto see how bad today is look at the master list of 52-week lows we compiled two hours ago with financials, restaurants, retail, REIT, property, tech and more. It’s a huge list.
Jon C. Ogg
January 4, 2008
Cash Back Credit Cards Have Never Been This Good
Credit card companies are at war, handing out free rewards and benefits to win the best customers. A good cash back card can be worth thousands of dollars a year in free money, not to mention other perks like travel, insurance, and access to fancy lounges. See our top picks for the best credit cards today. You won’t want to miss some of these offers.
Flywheel Publishing has partnered with CardRatings for our coverage of credit card products. Flywheel Publishing and CardRatings may receive a commission from card issuers.
Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.
Latest from 24/7
